United Therapeutics (NASDAQ: UTHR) proposed sale of 1,300 shares via option
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
United Therapeutics Corporation submitted a Form 144 notice to sell 1,300 shares of Common Stock via a stock option exercise to be effected on 03/30/2026. The filing lists prior open-market dispositions by Christopher Causey totaling multiple transactions in January–March 2026.
Positive
- None.
Negative
- None.
Key Figures
Proposed sale: 1,300 shares
Recent sale: 20 shares
Recent sale: 1,000 shares
+2 more
5 metrics
Proposed sale
1,300 shares
Stock Option Exercise on 03/30/2026
Recent sale
20 shares
Sold 03/04/2026 for $9,803.37
Recent sale
1,000 shares
Sold 02/25/2026 for $520,000.00
Recent sale
1,000 shares
Sold 01/06/2026 for $510,000.00
Recent sale
1,000 shares
Sold 01/02/2026 for $500,014.60
Key Terms
Form 144, Stock Option Exercise, Issuer
3 terms
Form 144 regulatory
"submitted a Form 144 notice to sell 1,300 shares"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Stock Option Exercise financial
"03/30/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
Issuer regulatory
"Stock Option Exercise | Issuer | ... | 1300"
FAQ
What does UTHR's Form 144 say about the sale?
It notifies of a proposed sale of 1,300 shares by way of a stock option exercise on 03/30/2026. The filing is a regulatory notice of intent to sell; actual settlement depends on the transaction taking place as described.
Who is the selling party named in the Form 144 for UTHR?
The filing identifies transactions by Christopher Causey in the past three months and lists the proposed sale tied to the issuer. Christopher Causey appears in the recent dispositions section with multiple dated sales and dollar amounts.
How large are the recent transactions disclosed in the filing?
The Form 144 shows a proposed sale of 1,300 shares on 03/30/2026. It also records prior sales: 20 shares for $9,803.37 and three separate 1,000-share sales with values of $520,000, $510,000, and $500,014.60.
Does the Form 144 state who receives proceeds from the sale?
The filing lists the transaction method as Cash and labels the party as Issuer. It therefore indicates cash proceeds flow in connection with an issuer stock option exercise as described in the notice.